$DXCM 0.53 Developing
- Date
- Jul 30, 2026
- Mentions
- 3
- Unique authors
- 2
- Sector
- biotech
- Stance
- bullish
- On card
- no
Sentiment history
No sentiment history available for $DXCM yet.
Sentiment
Notable posts
-
neutral 67 eng
Today's Key Events (All EST) β 07/30/2026 08:30: US PCE Price Index 08:30: US Initial Jobless Claims 08:30: US GDP QoQ Advance 08:30: US Consumer Spending Before Open π 05:00: Check Point Software $CHKP 05:00: Yum China $YUMC 06:00: Cigna $CI 06:00: Enterprise Products $EPD 06:00: CRH $CRH 06:00: Air Products $APD 06:30: Valero Energy $VLO 06:30: Norwegian Cruise Line $NCLH 06:30: Regeneron $REGN 06:30: TC Energy $TRP 06:30: Xerox $XRX 06:30: Trane Technologies $TT 06:45: Hershey $HSY 06:45: TechnipFMC $FTI 06:50: KKR $KKR 06:55: Bristol Myers Squibb $BMY 06:55: Ferrari $RACE 06:55: Quanta Services $PWR 06:55: American Electric Power $AEP 07:00: Crocs $CROX 07:00: Yum! Brands $YUM 08:00: Mastercard $MA After Hours π 16:00: Amazon $AMZN 16:00: DexCom $DXCM 16:00: Strategy $MSTR 16:00: First Solar $FSLR 16:00: Monolithic Power Systems $MPWR 16:00: Neurocrine Biosciences $NBIX 16:00: Tempus AI $TEM 16:05: Roblox $RBLX 16:05: Reddit $RDDT 16:05: Rivian $RIVN 16:05: GoDaddy $GDDY 16:05: Illumina $ILMN 16:05: Nextpower $NXT 16:05: Stryker $SYK 16:05: Universal Display $OLED 16:10: Live Nation $LYV 16:15: MasTec $MTZ 16:15: Coinbase $COIN 16:15: BigBear .ai $BBAI 16:15: Mohawk Industries $MHK 16:30: Apple $AAPL 16:30: Corteva $CTVA 17:10: Eldorado Gold $EGO 18:55: Vale $VALE 19:00: Sony
view on X β -
bullish 27 eng
DEXCOM $DXCM Q2β26 EARNINGS HIGHLIGHTS πΉ Revenue: $1.31B (Est. $1.29B) π’; +13% YoY πΉ Adj. EPS: $0.70 (Est. $0.61) π’; +46% YoY πΉ Non-GAAP Operating Income: $328.3M (Est. $286M) π’; +48% YoY πΉ Adjusted EBITDA: $421.3M (Est. $387M) π’ Raises FY26 Guide: πΉ Revenue: $5.18B-$5.25B (Est. $5.22B) π‘ πΉ Non-GAAP Gross Profit Margin: ~64% πΉ Non-GAAP Operating Margin: ~23.5%-24% πΉ Adjusted EBITDA Margin: ~31.5%-32% Geographic Revenue: πΉ U.S. Revenue: $933.4M; +11% YoY πΉ International Revenue: $375.0M; +19% YoY Other Q2 Metrics: πΉ Organic Revenue Growth: +12% YoY πΉ Non-GAAP Gross Margin: 64.1%; +400 bps YoY πΉ GAAP Operating Margin: 24.3%; +590 bps YoY Comments: πΈ βwe had the opportunity to host many of you at our 2026 Investor Day, where we highlighted our substantial market opportunity and introduced a new long-term financial outlook through 2030β πΈ βThis quarterβs performance and the successful outcomes from our CONNECT trial reinforce our confidence in the path ahead and position us well to deliver on our long-range plan.β
view on X β -
bullish 6 eng
DEXCOM $DXCM JUST REPORTED Q2 EARNINGS β’ Adjusted EPS of $0.70 beating expectations of $0.61 π’ β’ Revenue of $1.31B beating expectations of $1.29B π’ β’ Adjusted operating income of $328.3M beating expectations of $285.5M π’ β’ Adjusted net income of $269.1M beating expectations of $235.8M π’ β’ Adjusted gross profit of $838.5M β’ Gross profit of $830.0M β’ Operating income of $318.3M
view on X β
Only one day of history so far β the signal arc fills in as the daily job runs.